The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

4.09%Dividend Yield

Dec 25

$0.71

Dec 24

$0.18

Dec 23

$0.11

Dec 22

$0.01

Dec 21

$4.05

10Y Growth

N/A

5Y Growth

-29.33%

3Y Growth

85.02%

1Y Growth

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow KURE. It's not an investment recommendation.

KraneShares CSI China Internet

Invesco QQQ Trust Series 1

QQQ

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

State Street SPDR S&P China

GXC

Mkt Cap0

SPDR S&P China ETF tracks a broad-based, cap-weighted index of Chinese stocks, including health care, offering a diversified exposure to China's economy but competing with KURE in the healthcare segment.

iShares MSCI China

MCHI

Mkt Cap0

iShares MSCI China ETF tracks the MSCI China Index, which includes stocks across all sectors, including health care. It competes with KURE by offering exposure to Chinese healthcare companies as part of its broader portfolio.

KraneShares CSI China Internet

KWEB

Mkt Cap0

KraneShares CSI China Internet ETF focuses on Chinese internet companies, some of which are involved in health technology and services, indirectly competing with KURE in the healthcare technology space.

Xtrackers Harvest CSI 300 China A-Shares

ASHR

Mkt Cap0

Deutsche X-trackers Harvest CSI 300 China A-Shares ETF tracks the CSI 300 Index, which includes healthcare stocks among its largest components, competing with KURE for investors seeking exposure to Chinese healthcare.

iShares China Large-Cap

FXI

Mkt Cap0

iShares China Large-Cap ETF tracks the FTSE China 50 Index, including large-cap Chinese stocks across various sectors, including health care, thus competing with KURE for investment in the Chinese healthcare sector.

Invesco China Technology

CQQQ

Mkt Cap0

Invesco China Technology ETF focuses on technology in China, including health tech companies, making it a competitor to KURE by offering exposure to the tech side of healthcare.

WisdomTree China ex-State-Owned Enterprises Fund

CXSE

Mkt Cap0

WisdomTree China ex-State-Owned Enterprises Fund excludes SOEs and includes private healthcare companies, competing with KURE by targeting a different segment of the Chinese healthcare market.

Invesco Golden Dragon China

PGJ

Mkt Cap0

Invesco Golden Dragon China ETF tracks the NASDAQ Golden Dragon China Index, which includes U.S.-listed companies that derive a majority of their revenue from China, including healthcare firms, competing with KURE.

Holdings

Regions

Sectors

About

This exchange-traded fund will allocate at least 80% of its net assets, including any capital acquired through borrowing for investment purposes, to financial instruments that are components of its underlying index or exhibit similar economic characteristics. The reference index is a market capitalization-weighted measure, adjusted for free float, and applies a 10/40 Constraint. Its objective is to gauge the equity market performance of Chinese enterprises within the healthcare sector. This fund does not maintain a diversified portfolio.

CEO

Country

United States

ISIN

US5007678353

Listings

0 Comments

Share your thoughts

FAQ

What is KraneShares MSCI All China Health Care Index stock price today?▼

The current price of KURE is $18.43 USD — it has increased by +5.47% in the past 24 hours. Watch KraneShares MSCI All China Health Care Index stock price performance more closely on the chart.

What is KraneShares MSCI All China Health Care Index stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on ARCX exchange KraneShares MSCI All China Health Care Index stocks are traded under the ticker KURE.

Is KraneShares MSCI All China Health Care Index stock price growing?▼

KURE stock has risen by +7.03% compared to the previous week, the month change is a +10.75% rise, over the last year KraneShares MSCI All China Health Care Index has showed a -4.02% decrease.

Does KraneShares MSCI All China Health Care Index pay dividends?▼

Yes, KURE dividends are paid annual. The last dividend per share was 0.71 USD. As of today, Dividend Yield (FWD)% is 4.09%.

In which sector is KraneShares MSCI All China Health Care Index located?▼

KraneShares MSCI All China Health Care Index operates in the Other sector.

When did KraneShares MSCI All China Health Care Index complete a stock split?▼

KraneShares MSCI All China Health Care Index has not had any recent stock splits.